Vasoactive intestinal peptide and impotence in experimental diabetes mellitus

British Journal of Urology

Volumn 77, Issue 2, 1996, Pages 271-278

  Maher E ^a,c   Bachoo, M ^a   Elabbady, A A ^b   Polosa, C ^c   Beginj L R ^a   Collier, B ^a   Elhieali, M M ^b   Hassouna, M M ^a  

^a Department of Urology ^*  (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetic impotence; Experimental diabetes mellitus; Vasoactive intestinal peptide; VIP

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; IMPOTENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0030058748     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.88419.x     Document Type: Article

References (45)

1. Kolodny RC, Kahn CB, Goldstern HH, Barrett DM. Sexual dysfunction in diabetic men. Diabetes 1974; 23: 306
2. Clarke BF. Ewing ÜJ, Campbell W. Diabetic autonomie neuropathy. Diabetologia 1979: 17: 195-212
3. DeGroat WC. Steers WD. The neuroanatomy and neurophysiology of penile erection. In Tanagho E, Lue T, McClure T eds, Contemporary Management of Impotence and Infertility. Baltimore: Williams & Wilkins, 1988: 3-27
4. Faerman I, Glocer L. Fox D, Jadzinsky MN. Rapaport M. Impotence and diabetes. Histological studies of the autonomie nervous fibers of the corpora cavernosa in impotent diabetic males. Diabetes 1974; 23: 971-81
5. Burnett AL, Lowenstein CL. Bredt D. Chang TSK. Snyder SH. Nitric oxide: a physiological mediator of penile erection. Science 1992: 257: 401-3
6. Rajifer J, Aronson WJ, Bush PA. Dorey FJ. Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to non-adrenergic, non-cholinergic neurotransmission. N Engl J Med 1992:326:90-4
7. Huang PL. Dawson TM. Bredt DS. Snyder SH. Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993: 75: 1273-86
8. Dail WA. Minorsky N. Moll MA, Manzanares K. The hypogastric nerve pathway to penile erectile tissue: histochemical evidence supporting a vasodilator role. / Anton Nerv Syst 1986; 15: 341-9
9. Dail WA, Moll MA, Weber K. Localization of vasoactive intestinal polypeptide in penile erectile tissue and in the major pelvic ganglion of the cat. Neurosci 1983: 10: 1379-86
10. Ottesen B, Wagner G, Virag R. Fahrenkrug J. Penile erection; possible role of VIP as a neurotransmitter. Br Med } 1984; 288: 9-11
11. Steers WD, McConnell J, Bensen GS. Anatomical localization and some pharmacological effects of vasoactive intestinal polypeptide in human and monkey corpus cavernosum. / Urol 1984; 132: 1048-54
12. Takahashi Y, Aboseif SR, Bernard F, Stief CG. Lue TF. Tanagho EA. Effects of intracavernous simultaneous injection of acetylcholine and vasoactive intestinal polypeptide on canine penile erection. / Urol 1992; 148: 446-8
13. Polak JM, Gu J, Mina S, Bloom SR. VIPergic nerves in the penis. Lancet 1981; 2: 217-9
14. Anderson P-0. Bjornberg J. Bloom SR. Meilander S. V'asoactive intestinal polypeptide in relation to penile erection in the cat evoked by pelvic and by hypogactric nerve stimulation. / Ural 1987: 1 38: 419-22
15. 5 Aoki M. Matsuzaka J. Yeh K-H et al. Involvement of vasoactive intestinal peptide VIP: as a humoral mediator of penile erectile function in the dog. / Audrol 1994: 15: 174-82
16. Lincoln J. Crovve R. Blacklay PF. Pryor JP. Lumley JS. Burnstock G, Changes in the VIP-ergic. cholinergic and adrenergic innervation of human penile tissue in diabetic and non-diabetic impotent males. / Urol 1987: 157: 1053-9
17. Crowe R. Lincoln ). Blacklay PF. Pryor JP. Lumley JS. Burnstock C. Vasoactive intestinal polypeptide-like immunoreactive nerves in diabetic penis. A comparison between streptozotocin-treated rats and man. Diabetes 1983: 52: 1075-7
18. Makita Z. Volssara H. Cercimi. Bucola R Immunochemical detection of advanced glycosylation products in vivo. / Biol Chem 1992: 267: 5133-8
19. Zhao JB. Mikata A. Azuna K Immunoglobulin deposits in diabetic microangiopathy. Observations in autopsy materials. ActuPatli 1990: 40: 729-34
20. Brown C,L. Feldberg VV. The action of potassium on the superior cervical ganglion of the cat. / Physiol (Lond) 19 36: 86: 290-305
21. Hassan A. Hassouna M. Tabeto T, Gagnon C. Elhilali M. The effect of diabetes on sexual behaviour and reproductive tract function in male rats. / Urol 1993: 149: 148-54
22. Lowry OH. Rosenbrough NJ. Farr AL, Randall RJ. Protein determination with the Folin phenol reagent. / Biol Cliein 1951: 195: 265-75
23. ! YVelner SA. Collier B. Uptake, metabolism and releasability of ethyl analogues of homocholine by rat brain. / eiirochem 1984: 45: 1143-51
24. Goldberg AM. McCaman RE. Determination of picomole amounts of acelylcholine in mammalian brain. / Neurochetn 1973: 20: 1-8
25. Diani AR. Petcrson J. Sawada GA et al. Elevated levels of vasoactive intestinal peptide in the eye and urinary bladder of diabetic and prediabetic Chinese hamsters. Diabetoloifia 1985: 28: 302-7
26. Grozes 1. Brenneman DE. VIP: molecular biology and neurobiological function. Mol Rial 1989; 5: 201-20
27. Crovve R. Milner P. Lincoln J. Burnstock G. Histochemical and biochemical investigation of adrenergic cholinergic and peptidergic innervation of the rat ventral prostate 8 weeks after streptozotocin-induced diabetes. / Anton .Xcrv Sust 1987: 20: 103-12
28. Carvalho JL. Hudson NP. Blank MA et ni. Occurrence, distribution and origin of peptide containing nerves of guinea-pig and rat male gcnitalia. / Anat 1986: 149: 121-41
29. Loesch A. Belai A. Lincoln J. Burnstoek G. Enteric nerves in diabetic rats: electron microscopic evidence for neuropathy of vasoactive intestinal polypeptide-containing libres. Afin \ewopathol 1986: 70: 161-8
30. Bêlai A. Lincoln ]. Burn stock G. Lack of release of VIP and CGRP during electrical stimulation of enteric nerves in slreptozotocin-diabetic rats. Gtistroeiiterol 1987: 9: 1034-40
31. Thoenen H The changing scene of neurotrophic factors. 71X.S 1991: 14: 165-70
32. Heuser ]K. Reese TS. Structure of the synapse. In Kandel ER ed. Handbook of Physiology Section 1 : The Nervous System. Bethesda. Md: Ameriam Physiologicnl Society. 1977: 261-94
33. Belai A. Lincoln J. Milner R. Crow R. Loesch A. Burnstock G. Enteric nerves in diabetic rats. Increase in vasoactive intestinal polypeptide but not substance P. Gastroeuterol 1985: 89: 967-76
34. Moss HE. Crowe R. Burnstock A. The seminal vesicle in eight and 16 week streptozotocin-induced diabetic rats: adrenergic. cholinergic and peptidergic innervation. / Uroi 1987: 138: 1273-8
35. Ballmann M. Conlon JM. Changes in the somatostatin. substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozolocininduced diabetes in the rat. Diabctolagia 1985: 28: 355-8
36. Hokfelt T. Zhang X. Wisenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. 7V\.S' 1994:17:22-9
37. Xigmond RE. Hyatt-Sachs H. Baldwin C et al. Phenotypic plasticity in adult sympathetic neurons: changes in neuropeptide expression iti organ culture. Pnc \r/ Anid Sei 1992: 89: 1507-11
38. Brewster WJ. Fernyhough P. Diemel LT. Mohiuddin L. Tomlison DR. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. 7VNS 1994: 17: 321-5
39. Hellweg R. Härtung H-1). Endogenous levels of nerve growth factor NGF: are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. / \rwvsci Res 1990: 25: 258-67
40. Ordonez G. Fernandez A. Perez R. Sotelo J. Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice: a possible etiological element of diabetic neuropathy. / \eurological Sei 1994: 121: 163-6
41. Calcutt NA. Muis D. Powell HC. Mizisin AP. Reduced ciliary neurotrophic factor-like activity in nerves from diabetic or galactose-fed rats Rmin Res 1992: 575: 320-4
42. Kamato K. Sakamoto A. Kasuya Y. Changes in sensitivity of the rat stomach fundus to various drugs in streptozotocininduced diabetic rats. Japtm ] Pharmacol 1988: 47: 99-103
43. Sreedharan SP. Patel DR. Huang J-X. Goetzl EJ. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Rioeheni Kiophys Res Comm 1993: 193: 546-53
44. Turner JT. Bollinger DVV. Toews ML. Vasoactive intestinal peptide receptor/adenylate cyclase system: Differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization. / Pharmaeol Exp Tlu-r 1988; 247: 417-23
45. Abbracchio M P. Cattabeni F. DiGiulio AM. Fiaco C. Tenconi B. Gorio A. Early alterations of Gi/Go protein-dependent transductional processes in the retina of diabetic animals. / \cmusri Res 1991: 29: 196-200